Related Experiment Videos
The MCMI-II diagnosis of schizophrenia: operating characteristics and profile analysis
P M del Rosario1, J T McCann, J W Navarra
1State University of New York at Buffalo.
Abstract:
The Millon Clinical Multiaxial Inventory-II (MCMI-II) scores of 35 schizophrenic inpatients were compared with scores from a matched group of 35 psychiatric inpatients with no thought disorder. The operating characteristics of the Thought Disorder (SS) scale in overlapping and nonoverlapping form were determined using various cutoff points defined by Base Rate (BR) scores or the numbers of prototypic items endorsed by the subject. The Thought Disorder scale was found to perform poorly--no better than chance (Prevalence = 50%)--at correctly classifying patients as schizophrenic or nonschizophrenic, regardless of the type of cutoff lines used. A profile analysis was performed on six schizophrenia-relevant scales in search of a distinguishing schizophrenia profile. Results indicated that the schizophrenic group produced no distinct profile. Results are discussed in terms of their relevance for clinicians and further research.
Insights
The Millon Clinical Multiaxial Inventory-II's Thought Disorder scale poorly identifies schizophrenia, performing no better than chance. Schizophrenic patients also did not exhibit a distinct diagnostic profile on relevant scales.
Area of Science:
- Psychological assessment
- Clinical psychology
- Psychopathology research
Background:
- Accurate diagnosis of schizophrenia is crucial for effective treatment.
- The Millon Clinical Multiaxial Inventory-II (MCMI-II) is a tool used in psychiatric assessment.
- The Thought Disorder (SS) scale within the MCMI-II is intended to aid in identifying thought disorders, often associated with schizophrenia.
Purpose of the Study:
- To evaluate the diagnostic accuracy of the Thought Disorder (SS) scale of the MCMI-II in identifying schizophrenia.
- To determine if a distinct profile exists for schizophrenic patients on MCMI-II scales.
- To assess the clinical utility of the MCMI-II for differentiating schizophrenic from non-schizophrenic psychiatric inpatients.
Main Methods:
- Compared MCMI-II scores of 35 schizophrenic inpatients with 35 matched psychiatric inpatients without thought disorder.
- Analyzed the operating characteristics of the Thought Disorder (SS) scale using various cutoff points (Base Rate scores, prototypic items).
- Performed a profile analysis on six schizophrenia-relevant scales to identify a distinguishing schizophrenia profile.
Main Results:
- The Thought Disorder (SS) scale demonstrated poor performance, classifying patients no better than chance (50% prevalence).
- This poor performance was consistent across different cutoff points and scale configurations.
- No distinct diagnostic profile was identified for the schizophrenic group across the analyzed schizophrenia-relevant scales.
Conclusions:
- The MCMI-II Thought Disorder (SS) scale is not a reliable instrument for differentiating schizophrenic from non-schizophrenic psychiatric inpatients.
- Clinicians should exercise caution when using the MCMI-II for the specific diagnosis of schizophrenia.
- Further research is needed to explore alternative or supplementary diagnostic tools for schizophrenia assessment.